Trump Eyes Bipartisan Deals on Infrastructure and Drug Prices

March 26, 2019

U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said on Tuesday.

Conway said the Trump administration considered those two issues as areas of cooperation between Democrats and the Republican president.

Trump said in January that he expected to see a tremendous decrease in drug prices even as drugmakers have taken steps to raise the prices of medicines starting this month.

According to documents seen by Reuters, nearly 30 pharmaceutical companies have taken steps to end their self-declared halt to price increases this year.

Leaders in the Democrat-controlled House of Representatives say the high cost of prescription drug prices is a top priority for the year. Powerful committees held hearings in January on the matter.

The Republican-controlled Senate Finance Committee has invited executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines.

(Reporting by Alex Alper; Writing by Doina Chiacu; Editing by David Alexander, Jeffrey Benkoe and Bill Trott)

Was this article valuable?

Here are more articles you may enjoy.

Latest Comments

  • March 27, 2019 at 9:47 am
    Ron says:
    He has not gotten much done. Maybe the people in his administration and Congress, but not him. He is too busy campaigning, fundraising, hanging out with our enemies, trashing ... read more
  • March 27, 2019 at 9:44 am
    Ron says:
    He's been saying these things since his campaign. He's been the POTUS for over 2 years, including 2 years when Republicans held majorities in both houses of Congress. I alread... read more
  • March 26, 2019 at 4:20 pm
    Agent says:
    I am amazed he has gotten so much done already given the Witchhunt for the past two years that has been completely debunked. It is the responsibility of the lawmakers to try ... read more

Add a CommentSee All Comments (5)Add a Comment

Your email address will not be published. Required fields are marked *

*

More News
More News Features